Hexamethylcyclotriosiloxane does have some potential risks in medical applications, mainly reflected in the following aspects:
Chemical property related risks
Flammability risk: Hexamethylcyclotriosiloxane is a flammable substance, and its hazard category code indicates that it has highly flammable characteristics (hazard category code 11). In the medical environment, especially in scenarios where high temperatures, open flames, or static electricity are prone to fire hazards, such as the generation of heat during the operation of some medical equipment, or the use of flammable disinfectants during disinfection and other operations, if the area is not properly protected, it may cause fire accidents due to the flammability of hexamethylcyclotriosiloxane, thereby threatening the safety of patients, medical staff, and medical facilities.
Irritation risk: It is irritating to the eyes, respiratory system, and skin of the human body (hazard category code 36/37/38). In medical applications, whether in the production process of medical devices, workers may experience eye redness, pain, respiratory discomfort, coughing, skin itching, redness and swelling when exposed to it; During the use of medical devices with coatings and materials containing hexamethylcyclotriosiloxane, if the coating falls off, decomposes, or comes into contact with the released hexamethylcyclotriosiloxane, the human body may also face these irritant injuries, affecting the patient's physical recovery and the health of medical staff.
Biocompatibility and potential in vivo reaction risks
Biocompatibility issue: Although it has demonstrated many useful properties in medical applications, it is still a chemically synthesized substance, and the human body may have rejection reactions to foreign substances. When it is used in scenarios such as coatings for implantable medical devices or drug carriers that come into direct contact with internal tissues and body fluids, it may trigger immune reactions, leading to adverse consequences such as inflammation, affecting its normal use and the health status of patients.
Metabolism and Accumulation Risk in the Body: Currently, there is a lack of comprehensive and in-depth research on the long-term metabolic process of hexamethylcyclotriosiloxane in the human body and whether it accumulates. If it cannot be effectively metabolized and excreted in the body, but gradually accumulates, it may cause potential damage to the body's organs, especially for patients who need to use medical products containing this substance for a long time. This risk is more worthy of attention.
Stability and degradation product risk
In the process of medical applications, the stability of hexamethylcyclotriosiloxane may change over time and under the influence of complex internal environments in the human body, such as changes in acidity and alkalinity, enzyme activity, etc. Once it undergoes degradation or other situations, the safety of its degradation products is uncertain, and it may produce some toxic or more irritating substances, thereby posing new threats to human health.
However, it should be pointed out that in the current medical field, the application of hexamethylcyclotriosiloxane undergoes strict safety assessments, clinical trials, and other procedures, and is regulated in terms of dosage and usage methods to minimize potential risks and ensure its safety and effectiveness in medical applications.

Room termperature curing polysilazane, pls check IOTA 9150, IOTA 9150K.       
High termperature curing polysilazane, pls check IOTA 9108, IOTA 9118.